Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
BioNTech SE
Children's Oncology Group
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Milton S. Hershey Medical Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
SUNHO(China)BioPharmaceutical CO., Ltd.
Thomas Jefferson University
Fox Chase Cancer Center
Pfizer
Mayo Clinic
EMD Serono
Taiho Oncology, Inc.
Astex Pharmaceuticals, Inc.
Fudan University
ImmunityBio, Inc.
University of Birmingham
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Alliance Foundation Trials, LLC.
Rush University Medical Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Northwestern University
Duke University
Wake Forest University Health Sciences
Intergroupe Francophone de Cancerologie Thoracique
Universitaire Ziekenhuizen KU Leuven
University of Chicago
Canadian Cancer Trials Group
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
GlaxoSmithKline
Chong Kun Dang Pharmaceutical
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Aultman Health Foundation
GOG Foundation
National Cancer Institute (NCI)
GOG Foundation
University of California, Irvine
Masonic Cancer Center, University of Minnesota
The Methodist Hospital Research Institute
National Cancer Institute (NCI)